GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.2310
+0.0005 (0.22%)
Apr 2, 2025, 4:22 PM CET

GenSight Biologics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-14-26.22-27.63-28.62-34.02
Upgrade
Depreciation & Amortization
1.062.181.060.930.93
Upgrade
Stock-Based Compensation
0.780.59-3.364.833.46
Upgrade
Other Operating Activities
-1.65-3.660.090.889.02
Upgrade
Change in Accounts Receivable
--00.76-0.70.79
Upgrade
Change in Accounts Payable
0.16-2.23-2.152.40.34
Upgrade
Change in Other Net Operating Assets
0.724.69-2.523.144.43
Upgrade
Operating Cash Flow
-12.94-24.66-33.75-17.14-15.04
Upgrade
Capital Expenditures
--0.01-0.25-0.03-0.01
Upgrade
Investment in Securities
-0.220.420.02-
Upgrade
Other Investing Activities
0.02----0.37
Upgrade
Investing Cash Flow
0.020.210.17-0.02-0.38
Upgrade
Long-Term Debt Issued
-14.1810.8-11.71
Upgrade
Long-Term Debt Repaid
--1.87-8.68-3.65-0.71
Upgrade
Net Debt Issued (Repaid)
-12.312.12-3.6511
Upgrade
Issuance of Common Stock
-3.9603025.38
Upgrade
Repurchase of Common Stock
--0.1-0.19-0.31-
Upgrade
Other Financing Activities
13.54-0.31-1.83-2.3-2.52
Upgrade
Financing Cash Flow
13.5415.860.123.7433.86
Upgrade
Foreign Exchange Rate Adjustments
-0.290.12-0.19-0.240.25
Upgrade
Miscellaneous Cash Flow Adjustments
----0-
Upgrade
Net Cash Flow
0.33-8.48-33.686.3518.69
Upgrade
Free Cash Flow
-12.94-24.67-34.01-17.17-15.05
Upgrade
Free Cash Flow Margin
-492.84%-832.42%-698.97%-222.74%-202.28%
Upgrade
Free Cash Flow Per Share
-0.14-0.51-0.73-0.38-0.43
Upgrade
Cash Interest Paid
-0.371.870.840.71
Upgrade
Levered Free Cash Flow
-6.65-14.13-29.49-13.79-6.46
Upgrade
Unlevered Free Cash Flow
-5.72-12.16-27.83-12.43-5.38
Upgrade
Change in Net Working Capital
-2.33-3.647.880.59-5.83
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.